Is LFMD or FLGT more profitable?

LifeMD has a net margin of 0.10% compared to Fulgent Genetics' net margin of -26.05%. Fulgent Genetics' return on equity of -4.93% beat LifeMD's return on equity. Company Net Margins Return on Equity Return on Assets LifeMD 0.10% -168.23% -31.27% Fulgent Genetics -26.05% -4.93% -4.50%

Is SBC or LFMD more profitable?

SBC Medical Group has a net margin of 27.99% compared to LifeMD's net margin of 0.10%. SBC Medical Group's return on equity of 18.47% beat LifeMD's return on equity. Company Net Margins Return on Equity Return on Assets SBC Medical Group 27.99% 18.47% 13.10% LifeMD 0.10% -168.23% -31.27%

Does the media refer more to SBC or LFMD?

In the previous week, SBC Medical Group had 3 more articles in the media than LifeMD. MarketBeat recorded 5 mentions for SBC Medical Group and 2 mentions for LifeMD. LifeMD's average media sentiment score of 0.89 beat SBC Medical Group's score of 0.38 indicating that LifeMD is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SBC Medical Group 0 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral LifeMD 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer TACO or LFMD?

LifeMD has a consensus price target of $7.57, indicating a potential upside of 161.99%. Given LifeMD's stronger consensus rating and higher possible upside, analysts plainly believe LifeMD is more favorable than Berto Acquisition. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Berto Acquisition 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 LifeMD 1 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.70

Which has preferable earnings & valuation, TACO or LFMD?

LifeMD has higher revenue and earnings than Berto Acquisition. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Berto Acquisition N/A N/A N/A N/A N/A LifeMD $194.05M 0.72 $14.35M -$0.05 N/A

Does the media refer more to TACO or LFMD?

In the previous week, Berto Acquisition had 3 more articles in the media than LifeMD. MarketBeat recorded 5 mentions for Berto Acquisition and 2 mentions for LifeMD. Berto Acquisition's average media sentiment score of 1.17 beat LifeMD's score of 0.89 indicating that Berto Acquisition is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Berto Acquisition 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive LifeMD 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger valuation & earnings, VMD or LFMD?

Viemed Healthcare has higher revenue and earnings than LifeMD. LifeMD is trading at a lower price-to-earnings ratio than Viemed Healthcare, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Viemed Healthcare $270.28M 1.28 $14.93M $0.36 25.17 LifeMD $194.05M 0.72 $14.35M -$0.05 N/A

Is VMD or LFMD more profitable?

Viemed Healthcare has a net margin of 4.81% compared to LifeMD's net margin of 0.10%. Viemed Healthcare's return on equity of 10.16% beat LifeMD's return on equity. Company Net Margins Return on Equity Return on Assets Viemed Healthcare 4.81% 10.16% 7.22% LifeMD 0.10% -168.23% -31.27%

LifeMD (LFMD) Competitors

$2.89 -0.04 (-1.37%)

As of 11:42 AM Eastern

Compare

LFMD vs. FLGT, SBC, SRTA, TACO, and VMD

Should you buy LifeMD stock or one of its competitors? LifeMD's main competitors and comparable companies include Fulgent Genetics (FLGT), SBC Medical Group (SBC), Strata Critical Medical (SRTA), Berto Acquisition (TACO), and Viemed Healthcare (VMD). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does LifeMD compare to Fulgent Genetics?

LifeMD (NASDAQ:LFMD) and Fulgent Genetics (NASDAQ:FLGT) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, profitability, earnings, media sentiment, institutional ownership, risk and analyst recommendations.

LifeMD has higher earnings, but lower revenue than Fulgent Genetics. LifeMD is trading at a lower price-to-earnings ratio than Fulgent Genetics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LifeMD	$194.05M	0.72	$14.35M	-$0.05	N/A
Fulgent Genetics	$322.67M	1.87	-$60.51M	-$2.82	N/A

LifeMD has a net margin of 0.10% compared to Fulgent Genetics' net margin of -26.05%. Fulgent Genetics' return on equity of -4.93% beat LifeMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LifeMD	0.10%	-168.23%	-31.27%
Fulgent Genetics	-26.05%	-4.93%	-4.50%

LifeMD has a beta of 2.04, meaning that its stock price is 104% more volatile than the broader market. Comparatively, Fulgent Genetics has a beta of 0.93, meaning that its stock price is 7% less volatile than the broader market.

In the previous week, LifeMD had 1 more articles in the media than Fulgent Genetics. MarketBeat recorded 2 mentions for LifeMD and 1 mentions for Fulgent Genetics. Fulgent Genetics' average media sentiment score of 1.39 beat LifeMD's score of 0.89 indicating that Fulgent Genetics is being referred to more favorably in the news media.

Company	Overall Sentiment
LifeMD	Positive
Fulgent Genetics	Positive

LifeMD currently has a consensus price target of $7.57, suggesting a potential upside of 161.99%. Fulgent Genetics has a consensus price target of $27.50, suggesting a potential upside of 25.06%. Given LifeMD's stronger consensus rating and higher probable upside, analysts clearly believe LifeMD is more favorable than Fulgent Genetics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LifeMD	1 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.70
Fulgent Genetics	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

35.5% of LifeMD shares are held by institutional investors. Comparatively, 48.1% of Fulgent Genetics shares are held by institutional investors. 17.2% of LifeMD shares are held by company insiders. Comparatively, 36.2% of Fulgent Genetics shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

LifeMD and Fulgent Genetics tied by winning 8 of the 16 factors compared between the two stocks.

How does LifeMD compare to SBC Medical Group?

SBC Medical Group (NASDAQ:SBC) and LifeMD (NASDAQ:LFMD) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, media sentiment, valuation, institutional ownership, earnings, profitability, risk and analyst recommendations.

In the previous week, SBC Medical Group had 3 more articles in the media than LifeMD. MarketBeat recorded 5 mentions for SBC Medical Group and 2 mentions for LifeMD. LifeMD's average media sentiment score of 0.89 beat SBC Medical Group's score of 0.38 indicating that LifeMD is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
SBC Medical Group	0 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
LifeMD	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

SBC Medical Group has a beta of 0.63, suggesting that its share price is 37% less volatile than the broader market. Comparatively, LifeMD has a beta of 2.04, suggesting that its share price is 104% more volatile than the broader market.

SBC Medical Group has higher earnings, but lower revenue than LifeMD. LifeMD is trading at a lower price-to-earnings ratio than SBC Medical Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SBC Medical Group	$173.61M	2.87	$50.99M	$0.47	10.32
LifeMD	$194.05M	0.72	$14.35M	-$0.05	N/A

60.8% of SBC Medical Group shares are held by institutional investors. Comparatively, 35.5% of LifeMD shares are held by institutional investors. 81.7% of SBC Medical Group shares are held by insiders. Comparatively, 17.2% of LifeMD shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

SBC Medical Group currently has a consensus target price of $8.50, indicating a potential upside of 75.26%. LifeMD has a consensus target price of $7.57, indicating a potential upside of 161.99%. Given LifeMD's stronger consensus rating and higher possible upside, analysts plainly believe LifeMD is more favorable than SBC Medical Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SBC Medical Group	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67
LifeMD	1 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.70

SBC Medical Group has a net margin of 27.99% compared to LifeMD's net margin of 0.10%. SBC Medical Group's return on equity of 18.47% beat LifeMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SBC Medical Group	27.99%	18.47%	13.10%
LifeMD	0.10%	-168.23%	-31.27%

Summary

SBC Medical Group beats LifeMD on 10 of the 16 factors compared between the two stocks.

How does LifeMD compare to Strata Critical Medical?

Strata Critical Medical (NASDAQ:SRTA) and LifeMD (NASDAQ:LFMD) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, valuation, risk, media sentiment, dividends and analyst recommendations.

Strata Critical Medical has higher revenue and earnings than LifeMD. Strata Critical Medical is trading at a lower price-to-earnings ratio than LifeMD, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Strata Critical Medical	$197.14M	2.32	$41.35M	-$0.04	N/A
LifeMD	$194.05M	0.72	$14.35M	-$0.05	N/A

47.4% of Strata Critical Medical shares are owned by institutional investors. Comparatively, 35.5% of LifeMD shares are owned by institutional investors. 15.5% of Strata Critical Medical shares are owned by insiders. Comparatively, 17.2% of LifeMD shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Strata Critical Medical has a beta of 2.26, suggesting that its stock price is 126% more volatile than the broader market. Comparatively, LifeMD has a beta of 2.04, suggesting that its stock price is 104% more volatile than the broader market.

Strata Critical Medical has a net margin of 15.71% compared to LifeMD's net margin of 0.10%. Strata Critical Medical's return on equity of -2.97% beat LifeMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Strata Critical Medical	15.71%	-2.97%	-2.54%
LifeMD	0.10%	-168.23%	-31.27%

In the previous week, LifeMD had 1 more articles in the media than Strata Critical Medical. MarketBeat recorded 2 mentions for LifeMD and 1 mentions for Strata Critical Medical. Strata Critical Medical's average media sentiment score of 1.76 beat LifeMD's score of 0.89 indicating that Strata Critical Medical is being referred to more favorably in the media.

Company	Overall Sentiment
Strata Critical Medical	Very Positive
LifeMD	Positive

Strata Critical Medical presently has a consensus price target of $8.00, indicating a potential upside of 54.59%. LifeMD has a consensus price target of $7.57, indicating a potential upside of 161.99%. Given LifeMD's higher probable upside, analysts clearly believe LifeMD is more favorable than Strata Critical Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Strata Critical Medical	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.75
LifeMD	1 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.70

Summary

Strata Critical Medical beats LifeMD on 12 of the 17 factors compared between the two stocks.

How does LifeMD compare to Berto Acquisition?

Berto Acquisition (NASDAQ:TACO) and LifeMD (NASDAQ:LFMD) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their risk, dividends, analyst recommendations, institutional ownership, media sentiment, valuation, earnings and profitability.

35.5% of LifeMD shares are held by institutional investors. 17.2% of LifeMD shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

LifeMD has higher revenue and earnings than Berto Acquisition.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Berto Acquisition	N/A	N/A	N/A	N/A	N/A
LifeMD	$194.05M	0.72	$14.35M	-$0.05	N/A

LifeMD has a net margin of 0.10% compared to Berto Acquisition's net margin of 0.00%. Berto Acquisition's return on equity of 0.00% beat LifeMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Berto Acquisition	N/A	N/A	N/A
LifeMD	0.10%	-168.23%	-31.27%

In the previous week, Berto Acquisition had 3 more articles in the media than LifeMD. MarketBeat recorded 5 mentions for Berto Acquisition and 2 mentions for LifeMD. Berto Acquisition's average media sentiment score of 1.17 beat LifeMD's score of 0.89 indicating that Berto Acquisition is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Berto Acquisition	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
LifeMD	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

LifeMD has a consensus price target of $7.57, indicating a potential upside of 161.99%. Given LifeMD's stronger consensus rating and higher possible upside, analysts plainly believe LifeMD is more favorable than Berto Acquisition.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Berto Acquisition	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
LifeMD	1 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.70

Berto Acquisition has a beta of 0.08, indicating that its stock price is 92% less volatile than the broader market. Comparatively, LifeMD has a beta of 2.04, indicating that its stock price is 104% more volatile than the broader market.

Summary

LifeMD beats Berto Acquisition on 8 of the 12 factors compared between the two stocks.

How does LifeMD compare to Viemed Healthcare?

Viemed Healthcare (NASDAQ:VMD) and LifeMD (NASDAQ:LFMD) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, earnings, profitability, media sentiment, valuation and risk.

74.2% of Viemed Healthcare shares are held by institutional investors. Comparatively, 35.5% of LifeMD shares are held by institutional investors. 20.6% of Viemed Healthcare shares are held by insiders. Comparatively, 17.2% of LifeMD shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Viemed Healthcare presently has a consensus target price of $14.00, indicating a potential upside of 54.53%. LifeMD has a consensus target price of $7.57, indicating a potential upside of 161.99%. Given LifeMD's stronger consensus rating and higher probable upside, analysts plainly believe LifeMD is more favorable than Viemed Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Viemed Healthcare	0 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.25
LifeMD	1 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.70

In the previous week, LifeMD had 1 more articles in the media than Viemed Healthcare. MarketBeat recorded 2 mentions for LifeMD and 1 mentions for Viemed Healthcare. Viemed Healthcare's average media sentiment score of 1.82 beat LifeMD's score of 0.89 indicating that Viemed Healthcare is being referred to more favorably in the media.

Company	Overall Sentiment
Viemed Healthcare	Very Positive
LifeMD	Positive

Viemed Healthcare has a net margin of 4.81% compared to LifeMD's net margin of 0.10%. Viemed Healthcare's return on equity of 10.16% beat LifeMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Viemed Healthcare	4.81%	10.16%	7.22%
LifeMD	0.10%	-168.23%	-31.27%

Viemed Healthcare has higher revenue and earnings than LifeMD. LifeMD is trading at a lower price-to-earnings ratio than Viemed Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Viemed Healthcare	$270.28M	1.28	$14.93M	$0.36	25.17
LifeMD	$194.05M	0.72	$14.35M	-$0.05	N/A

Viemed Healthcare has a beta of 1.09, indicating that its share price is 9% more volatile than the broader market. Comparatively, LifeMD has a beta of 2.04, indicating that its share price is 104% more volatile than the broader market.

Summary

Viemed Healthcare beats LifeMD on 11 of the 16 factors compared between the two stocks.

Get LifeMD News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LFMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

LFMD vs. The Competition

Export

Metric	LifeMD	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$139.30M	$9.65B	$7.25B	$13.07B
Dividend Yield	N/A	2.59%	2.52%	14.03%
P/E Ratio	-57.79	34.52	274.89	25.68
Price / Sales	0.72	5.00	608.23	83.19
Price / Cash	N/A	24.19	28.02	35.00
Price / Book	6.02	5.16	10.52	6.40
Net Income	$14.35M	$315.68M	$3.50B	$360.20M
7 Day Performance	-12.42%	-2.55%	-2.97%	-2.58%
1 Month Performance	-7.96%	-1.03%	-4.15%	-3.92%
1 Year Performance	-55.12%	12.60%	13.08%	3.91%

LifeMD Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
LFMD LifeMD	3.1911 of 5 stars	$2.89 -1.4%	$7.57 +162.0%	-54.4%	$139.30M	$194.05M	N/A	384
FLGT Fulgent Genetics	3.256 of 5 stars	$21.54 -0.7%	$27.50 +27.7%	-1.0%	$596.80M	$323.93M	N/A	1,315
SBC SBC Medical Group	3.9935 of 5 stars	$5.14 +8.2%	$8.50 +65.4%	+17.8%	$488.52M	$173.61M	10.94	863	Analyst Downgrade
SRTA Strata Critical Medical	2.7949 of 5 stars	$5.40 +1.1%	$8.00 +48.1%	N/A	$472.41M	$197.14M	N/A	601	Positive News
TACO Berto Acquisition	N/A	$10.45 flat	N/A	+0.1%	$340.93M	N/A	N/A	7,892	Positive News Short Interest Decrease High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:LFMD) was last updated on 9/29/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

LifeMD (LFMD) Competitors

LFMD vs. FLGT, SBC, SRTA, TACO, and VMD

How does LifeMD compare to Fulgent Genetics?

Summary

How does LifeMD compare to SBC Medical Group?

Summary

How does LifeMD compare to Strata Critical Medical?

Summary

How does LifeMD compare to Berto Acquisition?

Summary

How does LifeMD compare to Viemed Healthcare?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

LFMD vs. The Competition

LifeMD Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

LifeMD (LFMD) Competitors

LFMD vs. FLGT, SBC, SRTA, TACO, and VMD

How does LifeMD compare to Fulgent Genetics?

Which has stronger valuation & earnings, LFMD or FLGT?

Is LFMD or FLGT more profitable?

Which has more risk & volatility, LFMD or FLGT?

Does the media favor LFMD or FLGT?

Do analysts rate LFMD or FLGT?

Do institutionals and insiders hold more shares of LFMD or FLGT?

Summary

How does LifeMD compare to SBC Medical Group?

Does the media refer more to SBC or LFMD?

Which has more volatility and risk, SBC or LFMD?

Which has higher earnings & valuation, SBC or LFMD?

Do insiders and institutionals believe in SBC or LFMD?

Do analysts prefer SBC or LFMD?

Is SBC or LFMD more profitable?

Summary

How does LifeMD compare to Strata Critical Medical?

Which has preferable valuation & earnings, SRTA or LFMD?

Do institutionals & insiders believe in SRTA or LFMD?

Which has more volatility & risk, SRTA or LFMD?

Is SRTA or LFMD more profitable?

Does the media prefer SRTA or LFMD?

Do analysts prefer SRTA or LFMD?

Summary

How does LifeMD compare to Berto Acquisition?

Do insiders and institutionals have more ownership in TACO or LFMD?

Which has preferable earnings & valuation, TACO or LFMD?

Is TACO or LFMD more profitable?

Does the media refer more to TACO or LFMD?

Do analysts prefer TACO or LFMD?

Which has more volatility and risk, TACO or LFMD?

Summary

How does LifeMD compare to Viemed Healthcare?

Do insiders & institutionals have more ownership in VMD or LFMD?

Do analysts prefer VMD or LFMD?

Does the media refer more to VMD or LFMD?

Is VMD or LFMD more profitable?

Which has stronger valuation & earnings, VMD or LFMD?

Which has more volatility & risk, VMD or LFMD?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

LFMD vs. The Competition

LifeMD Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools